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Using monoclonal antibodies, we have examined the expression pattern of MASH1, a basic helix-loop-helix 
protein that is a mammalian homolog of the Drosophila achaete-scute proteins. In Drosophila, achaete-scute 
genes are required for the determination of a subset of neurons. In the rat embryo, MASH1 expression is 
confined to subpopulations of neural precursor cells. The induction of MASH1 precedes, but is extinguished 
upon, overt neuronal differentiation. MASH1 is expressed in the forebrain by spatially restricted domains of 
neuroepithelium and in the peripheral nervous system exclusively by precursors of sympathetic and enteric 
neurons. The features of early and transient expression, in spatially restricted subpopulations of neural 
precursors, are similar to those observed for achaete-scute. Thus, the amino acid sequence conservation 
between MASHI and achaete-scute is reflected in a parallel conservation of cell type specificity of expression, 
similar to the case of mammalian MyoD and Drosophila nautilus. These data support the idea that 
helix-loop-helix proteins may represent an evolutionarily conserved family of cell-type determination genes, 
of which MASH1 is the first neural-specific member identified in vertebrates. 
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The achaete-scute complex (AS-C) of Drosophila mela- 
nogaster contains a family of related genes whose func- 
tion is required for the determination of certain neurons 
(Garcia-Bellido and Santamaria 1978; Garcia-Bellido 
1979; Ghysen and Dambly-Chaudiere 1988). Mutations 
in different genes of the complex prevent the appearance 
of positionally restricted subsets of sensory mother cells 
within the peripheral nervous system (PNS)(Dambly- 
Chaudiere and Ghysen 1987). The AS-C is also required 
for neuronal determination within the central nervous 
system (CNS)(Cabrera et al. 1987). Genes of the AS-C 
are known to interact genetically with a number of other 
loci, including daughterless (da), hairy (h), extramachro- 
chaete (emc), and several neurogenic genes such as 
Notch and Delta (Moscoso del Prado and Garcia-Bellido 
1984; Dambly-Chaudiere et al. 1988; Cabrera 1990). 
These genetic interactions have led to the idea that the 
achaete-scute g nes participate in a regulatory network 
that defines territories within the epithelium where sen- 
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sory organs will develop (Ghysen and Dambly-Chaudiere 
1989). However, the precise role of these genes in the 
process of neuroblast determination is still not clear. 
New insights into the function and regulation of AS-C 
genes have emerged from the determination of their nu- 
cleotide sequences (Campuzano et al. 1985; Villares and 
Cabrera 1987; Gonzalez et al. 1989) and from biochem- 
ical studies of structurally related genes in mammalian 
systems (Murre et al. 1989b; Davis et al. 1990). The ach- 
aete-scute proteins are members of a family of transcrip- 
tion factors with common dimerization and DNA-bind- 
ing motifs, called the basic helix-loop-helix (bHLH) 
family (Murre et al. 1989a, b). Another bHLH protein, 
called MyoD, is involved in myogenic determination i  
vertebrates (Davis et al. 1987), suggesting that the bHLH 
motif may define a family of cell-type determination 
genes (Weintraub et al. 1991). In vitro studies of MyoD 
and achaete-scute have revealed that they heterodimer- 
ize with other, ubiquitously expressed bHLH proteins 
called E12/E47 (Murre et al. 1989b), originally identi- 
fied as a transcription factor for immunoglobulin genes 
(Murre et al. 1989a). As E12 appears to be a mammalian 
homolog of da, the previously observed genetic interac- 
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tions between the achaete-scute and da genes (Dambly- 
Chaudiere t al. 1988) most likely reflect direct interac- 
tions between their protein products. 
Recently we isolated cDNAs encoding two mamma- 
lian homologs of achaete-scute, called MASH1 and 
MASH2 (Johnson et al. 1990), from MAH cells (Birren 
and Anderson 1990), a cell line derived from the sym- 
pathoadrenal sublineage of the neural crest. The se- 
quences of MASH1 and MASH2 in the bHLH region are 
more similar to those of achaete-scute han to those of 
other mammalian bHLH proteins. A similar observation 
has been made for mammalian and Drosophila MyoD 
(Michelson et al. 1990). Preliminary studies of MASH1 
and MASH2 mRNA expression by Northern blotting in 
different cell lines and tissues uggested that MASH1, at 
least, is expressed in the developing nervous system 
(Johnson et al. 1990). However, these initial experiments 
did not examine MASH1 expression at the cellular level 
or reveal the precise time, lineage specificity, and spatial 
pattern of MASH1 expression, nor did they examine the 
expression of the MASH1 protein. 
To address these questions, we have raised specific 
monoclonal antibodies to MASH1 and used them to lo- 
calize the MASH1 protein in developing rat embryos. We 
find that MASH1 expression is specific to the nervous 
system, but precedes overt neuronal differentiation by 
12-24 hr. Moreover, in the brain MASH1 is expressed by 
subsets of neuroepithelial cells, and in the PNS exclu- 
sively by precursors in the sympathoadrenal/enteric sub- 
lineage. MASH1 expression is transient; the protein dis- 
appears concomitantly with the expression of neuron- 
specific differentiation markers uch as neurofilament or
SCG10. These features of transient and spatially re- 
stricted expression are similar to those exhibited by 
achaete-scute mRNAs (Cabrera et al. 1987; Romani et 
al. 1989) and protein (P. Cubas, J.-F. Celis, S. Cam -
puzano, and J. Modolell, in prep.) in Drosophila. This 
similarity, taken together with the sequence homology 
between MASH1 and achaete-scute, supports the idea 
that MASH 1 plays a role in neural determination i  ver- 
tebrates. 
Resu l ts  
Isolation and characterization ofmonoclonal 
antibodies to MASH1 
To obtain specific antibodies to MASH1, we overex- 
pressed the protein in Esherichia coli and immunized 
mice with gel-purified material (see Materials and meth- 
ods). From >800 hybridomas screened, we obtained -40 
producing antibodies that reacted specifically with the 
bacterially expressed protein. Of these, two antibodies, 
called anti-MASH1A and -MASH1B, reacted with the en- 
dogenous MASH1 protein in fixed embryo sections 
(most of the other antibodies failed to do so). These an- 
tibodies also stained the nuclei of PC12 and MAH cells, 
two cell lines known to express MASH1 mRNA 
(Johnson et al. 1990), but did not stain RAT1 fibroblasts, 
which do not express MASH1 mRNA (data not shown). 
The data presented here were obtained with anti- 
MASH1A, although anti-MASH1B yielded similar re- 
sults in selected samples (not shown). 
The specificity of the anti-MASH1 monoclonal anti- 
bodies was characterized in two ways. In the first 
method, MASH1, MASH2, and a rat El2 protein (S. Bir- 
ren and D.J. Anderson, unpubl.) were synthesized in a 
reticulocyte lysate from synthetic mRNA transcribed 
from their cognate cDNA clones (Fig. 1A, lanes 1-3). 
Immunoprecipitation with anti-MASH1A revealed reac- 
tivity of the antibody toward MASH1 but not toward 
MASH2 or El2 (Fig. 1A, lanes 4-6). No bands were im- 
munoprecipitated with a control antibody of the same 
subclass (Fig. 1A, lanes 7-9). Thus, the antibody recog- 
nizes MASH1 as distinct from MASH2 or El2. As 
MASH1 and MASH2 are >90% identical in their se- 
quence in the bHLH region, this experiment suggests 
that the epitope detected by anti-MASH1A lies outside 
this region. This makes it highly unlikely that the anti- 
MASH1A antibody is cross-reactive with other bHLH 
proteins, which are related primarily in this core region. 
Similar results were obtained with anti-MASH1B (not 
shown). 
Antibody characterization was also performed by 
Western blotting. Anti-MASH1A detected a closely 
spaced 34-kD doublet in MAH cells, the sympathoadre- 
nal progenitor cell line used to isolate the MASH1 cDNA 
[Fig. 1B, lanes 9,10 (arrow)]. This doublet may reflect 
translational initiation at either of two methionines 
spaced 7 amino acid residues apart (Johnson et al. 1990) 
or a post-translational modification. No polypeptides 
other than MASH1 were detected in MAH cells by the 
antibody (lane 10; cf. also lanes 4 and 9). No specific band 
was detected in RAT1 fibroblasts, a control cell line that 
does not express MASH1 mRNA (Fig. 1B; cf. lanes 8 and 
3). The 34-kD doublet was also detected in embryonic 
day (E) 12.5 and E13.5 brain (Fig. 1B, lanes 6,7), but not 
liver (cf. lanes 1 and 5), consistent with the specificity of 
MASH1 mRNA expression in these embryonic tissues 
(Johnson et al. 1990). Taken together, these data suggest 
that the anti-MASH1A antibody is highly specific for 
MASH1 and cross-reacts neither with related bHLH pro- 
teins nor with other proteins in cell lines and in em- 
bryos. 
Expression of MASH1 in the developing CNS 
Rat embryos taged from E7.5 to E13.5 were serially sec- 
tioned and stained with monoclonal anti-MASH1. Stain- 
ing was visualized by using either fluorescently labeled 
or horseradish peroxidase-conjugated secondary anti- 
body. No specific labeling was detected at any stage prior 
to El0.5, by which time primary neural induction and 
neurulation have occurred. MASH1 expression was first 
detected in the CNS at El0.5, a stage preceding the ex- 
pression of differentiation markers such as neurofila- 
ment (Fig. 2). In the brain, clusters of MASHl-labeled 
nuclei could be seen in the roof of the presumptive mes- 
encephalon (Fig. 2A, arrow) and the diencephalon (Fig. 
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Figure 1. Specificity of anti-MASH1 monoclonal an- 
tibodies. (A) Anti-MASHIA does not cross-react with 
either MASH2 or El2. MASH1 (M1), MASH2 (M2), 
and El2 proteins were transcribed and translated in 
vitro from their espective cDNA clones in the pres- 
ence of L-[3SS]methionine. Lanes 1-3 show the total 
translation products. Aliquots of these reactions were 
immunoprecipitated with either anti-MASH 1A (lanes 
4-6) or a control monoclonal IgG (lanes 7-9) and pro- 
tein G-Sepharose as the immunoadsorbent. The prod- 
ucts were analyzed by SDS-PAGE and fluorography. 
Note that the anti-MASH1A antibody is able to pre- 
cipitate only the 34-kD MASH1 protein and neither 
MASH2 nor El2. Molecular masses of standard pro- 
teins (Bio-Rad) run in an adjacent lane are indicated at 
left. (B) Western blot analysis of anti-MASHIA spec- 
ificity. The 34-kD MASH1 doublet is detected in ex- 
tracts of MAH cells (lane 9, arrow), E12.5 and E13.5 
(Br) (lanes 7 and 6, respectively), but not in RAT1 fi- 
broblasts (lane 8) or E13.5 liver (lane 5). This doublet 
is also seen for in vitro-translated MASH1 (A, lane 1; 
data not shown.) The higher molecular mass bands on 
the blot are artifacts of the avidin-biotin method, as 
shown by control blots lacking primary antibody 
(lanes 1-4); they are absent if the blot is developed 
with a less sensitive but more specific HRP-conju- 
gated secondary antibody (lane 10). Although not 
clearly visible in this reproduction, all bands seen in 
E13.5 brain except he 34-kD MASH1 doublet (lane 6) 
were also visible in the control acking primary anti- 
body (lane 2). Protein (120 ~g from each cell line and 
300 ~g from each embryonic tissue) was loaded on the 
gel. (MW) Molecular mass tandards. 
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2B, arrow). Small clusters of faintly stained nuclei were 
also observed in the ventral telencephalon (Fig. 2A; data 
not shown.) In the developing neural tube, a small num- 
ber of strongly labeled nuclei were visible flanking the 
floor plate (Fig. 2C,D, arrows.) MASH1 expression flank- 
ing the floor plate extends rostrally as far as the posterior 
hindbrain (Fig. 2B, arrowhead) but is not detected in the 
most caudal regions of the neural tube (Fig. 2A). Occa- 
sionally, stained nuclei are observed within the floor 
plate itself (not shown). 
By Ell .5, labeled nuclei adjacent to the floor plate 
have become more numerous (Fig. 3A, C, arrows). At this 
stage, MASH1 labeling is also detected in the dorsal, but 
not the intermediate, region of the neural tube (Fig. 3C, 
arrowheads). When developing motor neurons are visu- 
alized by counterstaining sections with antibodies to 
SCG10, a neuron-specific differentiation marker (Stein 
et al. 1988), it is apparent hat MASHl-positive nuclei 
occupy a discrete, intermediate region between the floor 
plate and the SCG10-positive motor neurons (Fig. 3; cf. A 
with B and C with D), a region designated as X by Ya- 
mada et al. (1991). At this stage of development, SCG10 
is not yet detectable in the dorsal neural tube (Fig. 3D), 
indicating that MASH1 expression precedes that of this 
marker. The segregation of MASH 1-positive nuclei to 
the dorsal and ventral regions of the neural tube suggests 
that MASH1 expression is positionally restricted with 
respect o the dorsoventral axis of the developing spinal 
cord. However, the spread of MASH1 expression within 
the dorsal region varies with anterior-posterior position 
and with stage of development. 
By E13.5, the spinal cord contains a well-defined ven- 
tricular zone (Fig. 4B, vz) containing mitotic neuroepi- 
thelial precursors. Following their terminal mitosis in 
the ventricular zone, neuroblasts migrate laterally to the 
marginal zone (Fig. 4B, mz)where  they differentiate. 
Thus, newly differentiated neurons and their precursors 
can be visualized simultaneously in spinal cord sections 
at this stage of development. MASHl-posit ive nuclei are 
restricted to the ventricular zone, in the dorsal aspect of 
the spinal cord (Fig. 4A, arrow). In contrast, cells in the 
marginal zone expressing terminal differentiation mark- 
ers such as SCG10 (Fig. 4B) and neurofi lament (Fig. 4C) 
are MASH1 negative (Fig. 4A, arrowhead). These obser- 
vations suggest hat MASH1 expression ot only pre- 
cedes the expression of terminal differentiation markers 
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Figure 2. Initial expression of MASH1 is detected in local regions of the ElO.5 CNS. (A,B) Frontal sections illustrating MASH1- 
positive nuclei in the roof of the midbrain (arrow, A) and the roof of the diencephalon (arrow, B). Immunoperoxidase (C) and 
immunofluorescence (D) localization of MASH1 immunoreactivity n nuclei (arrows) adjacent to he floor plate in the trunk region of 
the neural tube. Positive nuclei in the floor plate region are also seen in the hindbrain (B, arrowhead). Bars: (A) 156 ~m; (C) 40 ~m; 
(D) 32 ~m. 
but is also extinguished concomitant with the appear- 
ance of such markers. 
MASH1 expression is also positionally restricted in 
the developing forebrain. For example, in transverse sec- 
tions a well-defined, bilaterally symmetric band of la- 
beled nuclei is seen in the E11.5 diencephalon, posterior 
to the telencephalic boundary [Fig. 5A, di (arrows)]. As in 
the spinal cord, the MASHl-positive zones in the dien- 
cephalon are devoid of neurofilament staining (Fig. 5B). 
Restricted zones of expression are also visible in the my- 
elencephalon [Fig. 5A, my (arrowheads)]. Some neurofil- 
ament staining is visible at this stage in the margins of 
the myelencephalon (Fig. 5B, arrows), but this staining 
only partially overlaps the distribution of MASH l-posi- 
tive nuclei. By E12.5, the band of MASH1 expression in 
the diencephalon has become more pronounced (Fig. 5C, 
di). The anterior boundary of this band appears to corre- 
late with the boundary between the diencephalon and 
telencephalon (located ventral to the section illustrated), 
but the posterior boundary of the band oes not correlate 
with any structure. 
Studies in other systems have suggested that post- 
transcriptional mechanisms may regulate the expression 
of some bHLH genes (for review, see Weintraub et al. 
1991). We were therefore interested in comparing the 
pattern of MASH1 mRNA and protein expression. The 
time of onset of MASH1 protein expression in the brain 
is similar to that observed for MASH1 mRNA (Johnson 
et al. 1990). The same appears true of the spatial distri- 
bution of MASH1 expression. In frontal sections of E13.5 
midbrain, the MASHl-positive band in the diencephalon 
can be seen to extend dorsally to the boundary with the 
mesencephalon (Fig. 6A, arrowhead). In situ hybridiza- 
tion of similar sections with a MASHl-specific cRNA 
probe (Fig. 6B) suggests that the distribution of MASH1 
mRNA corresponds to that of the MASH1 protein. A 
similar correspondence between MASH1 protein and 
mRNA expression was also seen in sections of E13.5 
spinal cord (data not shown). Thus, the available data fail 
to suggest evidence of post-transcriptional regulation for 
MASH1. In this respect the regulation of MASH1 ap- 
pears similar to that of achaete and scute in the Droso- 
phila wing imaginal disc (P. Cubas et al. 1991). 
MASHl-positive nuclei also occupy a spatially re- 
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Figure 3. Expression of MASH1 in the Ell.5 neural tube is distinct from that of a marker of terminal neuronal differentiation. 
Double-labeling was performed with anti-MASH1 (A, C) and anti-SCG 10 (B,D). (A,B) Ventral region of the neural tube. Note that the 
MASHl-positive nuclei flank the floor plate (B, fp) and do not overlap the majority of developing motor neurons expressing SCGIO (B, 
arrowheads). (no), Notochord. (C,D) MASH1 is expressed in dorsal (C, arrowheads) as well as ventral (C, arrows)neural tube. Note that 
SCG10 immunoreactivity has not yet appeared in the dorsal neural tube (D). Asterisk (*) in A indicates autofluorescent blood cells; 
sg in C indicates ympathetic ganglion. Bars: (A) 43 }xm; (C) 85 ~m. 
stricted region in the presumptive cortex. In the E12.5 
telencephalon, staining is confined to the basal region 
(Fig. 7D, long arrow.) The posterior boundary of MASH1 
expression in the basal telencephalon respects the 
boundary with the diencephalon (Fig. 7D, arrowhead); 
however, the anterior boundary of staining is less sharply 
defined and has no morphologic orrelate. The spatial 
restriction of MASH1 expression in the telencephalon is 
seen more dramatically in serial reconstruction of 
parasaggital sections [Fig. 7A (tel); C (arrow)]. This re- 
construction also revealed widespread but patchy stain- 
ing in the superior colliculus, metencephalon, and mye- 
lencephalon (Fig. 7B, arrows). The restricted expression 
of MASH 1 in the forebrain does not result from temporal 
gradients of development, as expression did not extend 
into the dorsal region of the telencephalon at later stages. 
Rather, MASH1 expression in the forebrain becomes 
even more restricted with subsequent development, be- 
coming localized to the presumptive basal ganglia and 
optic chiasm at E13.5 (not shown). Staining of selected 
sections of adult brain and olfactory epithelium with 
anti-MASH1A has thus far failed to reveal any detectable 
immunoreactivity (L. Lo, unpubl.). 
Expression of MASH1 in the developing PNS 
In the rat, neural crest migration occurs between E10.5- 
Ell.5 in the trunk. MASH1 expression was not detect- 
able in migrating neural crest cells lateral to the neural 
tube (Fig. 2C,D and data not shown.) However, by E11- 
11.5, a population of MASHl-positive nuclei could be 
observed adjacent o the dorsal aorta, in the sympathetic 
ganglion anlage (Fig. 8A, arrowheads). Pronounced clus- 
tering of these nuclei could be seen in tangential sections 
(Fig. 8B, arrows). In frontal (longitudinal) sections, the 
MASH 1-positive cells appeared as a regularly spaced 
chain of clumps bordering the aorta (Fig. 8C, arrows.) In 
adjacent serial sections, cells in the same position as the 
MASH 1-positive nuclei expressed low-affinity nerve 
growth factor receptor (LNGFR) (not shown), a surface 
marker present on many early rat neural crest cells (D. 
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Figure 4. MASH1 expression is restricted to the ventricular 
zone of the E13.5 neural tube. Consecutive serial sections 
stained with monoclonal nti-MASH1 (A), SCG10 (B) and neu- 
rofilament (C). (B) (vz) Ventricular zone; (mz) marginal zone. 
Arrow in A indicates MASHl-positive nuclei in the dorsal ven- 
tricular zone; staining is absent from the marginal zone (arrow- 
head in A). Conversely, both SCG10 (arrow in B) and neurofil- 
ament (C) are expressed in the marginal zone but not the ven- 
tricular zone. Note that by this stage of development, MASH1 
staining has disappeared from the floor plate region (A). Bar, 100 
~m. 
Stemple, unpubl.). However, for technical reasons dou- 
ble-labeling with the two antibodies could not be per- 
formed. Nevertheless, the position of the MASHl-posi- 
tive nuclei and their likely coexpression of LNGFR 
strongly suggest that they are neural crest derived. Scat- 
tered MASH 1-positive cells were also detected ventral to 
the sympathetic ganglia in the developing ut where n- 
teric neurons are later generated [Fig. 9A (g and small 
arrows)]. MASH1 staining was not detected at any stage 
examined in dorsal root ganglia (containing sensory neu- 
rons), in the Schwann cells associated with ventral roots, 
or in the subectodermal region where melanocyte pre- 
cursors would be found. 
The relationship of MASH 1 expression to hat of other 
markers expressed by sympathetic neuronal precursors 
was examined by performing double-labeling experi- 
ments. At Ell.5, a few weakly SCG10-positive cells 
could be detected in the area containing MASHl-posi- 
tive nuclei (Fig. 9C, D, arrows.) It was not possible to 
determine at this level of resolution whether individual 
cells coexpressed both markers, although they are clearly 
present in the same region. A marker specific for sym- 
pathetic neurons is tyrosine hydroxylase (TH), the rate- 
limiting enzyme in catecholamine biosynthesis. Double- 
labeling experiments showed no detectable TH immu- 
noreactivity in the MASHl-positive cell clusters at E11- 
11.5 (not shown.) At E12.5, however, TH was strongly 
expressed in sympathetic ganglia, in regions overlapping 
the MASHl-positive nuclei (Fig. 10A, B, short arrows). 
However, the regions of strongest MASH1 staining ap- 
peared to correspond to TH-negative regions (cf. long ar- 
rows in Fig. 10A, B). The relative levels of TH and 
MASH1 staining in E12.5 sympathetic ganglia differed 
according to axial position within a given embryo, fol- 
lowing the rostrocaudal gradient of neural development: 
In younger caudal ganglia, loose aggregates of strongly 
MASHl-positive nuclei could be seen, but few TH-pos- 
itive cells were visible (Fig. 10C, D, uppermost long ar- 
rows); in contrast, in more anterior ganglia, only faint 
MASH1 staining could be seen in the TH-positive gan- 
glia (Fig. 10C, D, lower long arrows). By E13.5, MASH1 
staining has essentially disappeared from the ganglia, al- 
though occasional positive cells can be seen (data not 
shown). The reciprocal patterns of MASH1 and TH ex- 
pression in developing sympathetic ganglia strongly sug- 
gest that as in the CNS, precursor cells extinguish 
MASH1 expression as they activate xpression of differ- 
entiation markers. 
Discuss ion  
The expression pattern of MASH1 is analogous to that 
of Drosophila chaete-scute 
Emerging evidence suggests that bHLH proteins are in- 
volved in the process of cell-type determination (Wein- 
traub et al. 1991). In Drosophila, bHLH proteins encoded 
by the achaete-scute complex are required for the deter- 
mination of subsets of neurons (for review, see Ghysen 
and Dambly-Chaudiere 1988). We have used a monoclo- 
nal antibody to examine the xpression pattern of 
MASH1, a mammalian protein that shares 88% amino 
acid sequence identity with achaete-scute in its bHLH 
region (Johnson et al. 1990). Our results point to several 
analogies in the main features of MASH1 and achaete- 
scute expression. First, MASH1 is expressed specifically 
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Figure 5. MASH1 expression ispositionally restricted within the developing forebrain. (A,B) Consecutive transverse ctions through 
E11.5 forebrain stained with anti-MASH1 (A) or anti-neurofilament (B).Bands of MASHl-positive nuclei (arrows in A) are visible near 
the boundary between the diencephalon (di) and telencephalon (tel). No neurofilament staining is apparent in the diencephalon at this 
stage of development (B). MASHl-positive nuclei (arrowheads in A) are also apparent in the myelencephalon (my); some neurofilament 
expression is detectable in the marginal zone (arrows in B). (C) Transverse section through the myelencephalon (my) and diencephalon 
(di) of an E12.5 embryo. The plane of section is just dorsal to the outpocketing of the telencephalic vesicles. Note the well-defined 
boundaries of MASH1 expression i  the diencephalon (arrows). Anterior is down; posterior is up. Bars: (A) 160 ~m; (C) 125 ~m. 
in both the developing CNS and PNS, and the achaete- 
scute genes are required for the development of neurons 
in both the CNS and PNS. Second, MASH1 expression 
appears to be localized to subsets of neuroepithelial cells. 
In the Drosophila PNS, the achaete-scute complex is 
required for the determination of a subset of sensory 
mother cells that give rise to external sensory (es) organs 
(Ghysen and O'Kane 1989}. Third, expression of MASH1 
precedes overt neuronal differentiation, as determined 
by the expression of neuron-specific markers such as 
SCG 10 and neurofilament. In the Drosophila wing imag- 
inal disc, the achaete protein appears in sensory mother 
cells two divisions prior to the differentiation of sensory 
neurons (Romani et al. 1989; P. Cubas et al. 1991). 
Fourth, MASH 1 expression is transient, becoming extin- 
guished at or before overt differentiation. Similarly, in 
the wing imaginal disc, expression of the achaete protein 
is extinguished as the sensory mother cells initiate their 
terminal cell divisions (P. Cubas et al. 1991 ). These sim- 
ilarities in MASH1 and achaete-scute expression, taken 
together with their conservation of amino acid sequence, 
support he notion that MASH1 is a vertebrate neuronal 
determination gene. 
Evolutionary conservation of cell type determination 
The observation that MASH1 is expressed specifically in 
early neuroepithelial precursor cells, like achaete-scute, 
parallels the observations that the Drosophila and Caen- 
orhabditis elegans homologs of MyoD are expressed 
specifically in myogenic precursors, like their vertebrate 
counterparts (Krause et al. 1990; Michelson et al. 1990). 
Taken together, these data suggest hat there has been a 
parallel evolutionary conservation of amino acid se- 
quence and cell type specificity for at least some bHLH 
genes. Such conservation is consistent with the idea 
(Weintraub et al. 1991) that these genes comprise a fam- 
ily of cell-type determination factors. However, there are 
differences between the expression patterns of myogenic 
and neurogenic bHLH genes in their respective lineages. 
Both MASH1 and achaete-scute expression are extin- 
guished at or before overt differentiation. In contrast, the 
myogenic bHLH genes are expressed not only before but 
also after the onset of myogenesis (Sassoon et al. 1989). 
Because myogenic bHLH proteins are able to activate the 
transcription of muscle-specific structural genes (Lassar 
et al. 1989), it is thought hat they are not only involved 
in determination but also in differentiation. I  contrast, 
it seems unlikely that MASH1 is directly involved in 
maintaining the differentiated state. MyoD and MASH1 
may therefore act in their respective lineages at stages 
that are overlapping but distinct. Evidence from Droso- 
phila suggests that there are other neural-specific bHLH 
genes expressed later in development than achaete-scute 
(Jan and Jan 1990); perhaps the development of neuro- 
genic lineages occurs through a cascade of related genes. 
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Figure 6. MASH1 mRNA expression corresponds to MASH1 protein expression. (A) Frontal section through E13.5 forebrain just 
posterior to the telencephalic vesicles, stained with ti-MASH1 antibody. The band of labeled nuclei in the ventricular zone of the 
diencephalon (di) is similar to that seen i  Fig. 5C, but the plane of section is perpendicular, revealing the dorsal boundary of staining 
(arrowhead) near the junction with the mesencephalon (rues). (B) A similar section from a different mbryo f the same age was 
hybridized in situ with a MASH1 antisense cRNA probe (see Materials and methods). A 14-day exposure isshown. Note that the area 
of high-grain density (arrows) corresponds to that seen with the antibody. Control hybridizations with an antisense SCG10 probe 
showed grain accumulations over the marginal zone but not in the MASHl-positive ventricular zone (not shown). Bar, 91 ~m. 
Control of MASH1 expression 
The pattern of MASH1 expression raises the question of 
what factor(s) regulate the expression of this presump- 
tive regulatory protein. In the developing spinal cord, 
MASHl-positive nuclei are found adjacent o the floor 
plate. A recent series of experiments has revealed that 
the floor plate possesses an inductive activity that is able 
to pattern the development of the ventral spinal cord 
(Yamada et al. 1991), raising the possibility that the floor 
plate may activate expression of MASH1 in adjacent 
cells. One substance that has been implicated as a pos- 
sible floor plate-derived inducer is retinoic acid (Wagner 
et al. 1990). In this respect, it is of interest hat MASH1 
expression is induced by retinoic acid in P19 cells, an 
embryonal carcinoma cell line (J.E. Johnson, unpubl.). 
However, the observation that MASH1 is also expressed 
in the dorsal neural tube implies that the floor plate is 
not the exclusive inducer of MASH1 expression. Rather, 
MASH1 is likely to be regulated by different factors in 
different regions of the nervous ystem. 
MASH1 expression as evidence of a prepattern 
in the developing forebrain 
In the developing CNS, MASH1 appears to be expressed 
in spatially restricted subsets of neuroepithelial cells. In 
the forebrain, in particular, restricted zones of MASH1- 
positive nuclei are observed. In some areas, the bound- 
aries of MASH1 expression correlate with morphologic 
boundaries between structures, uch as the diencephalon 
and telencephalon; in other regions, MASH1 boundaries 
exist in a seemingly homogeneous neuroepithelium. The 
restricted omain of MASH1 expression i  the basal tel- 
encephalon is particularly striking (Fig. 7). Although the 
telencephalon has not yet been fate-mapped, the region 
of MASH1 expression may correspond to he presump- 
tive basal ganglia. Spatially restricted omains of tran- 
scription factor expression have been shown to precede 
overt patterning in the hindbrain (Wilkinson et al. 1989) 
and to correspond to cell lineage compartments (for re- 
view, see Lumsden 1990). Recent cell-lineage analyses 
have supported the existence of compartment-like 
boundaries to cell mixing along the anteroposterior axis 
of the forebrain (Austin and Cepko 1990; Crandall and 
Herrup 1990; Fishell et al. 1990): To our knowledge, the 
restricted expression of MASH1 represents the first ex- 
ample of spatially restricted transcription factor expres- 
sion in the embryonic forebrain. It will be necessary to 
map the fate of the MASHl-expressing cells before the 
relationship of the expression pattern to cell lineage 
boundaries or functional subdivisions in the forebrain 
can be adequately assessed. 
MASH1 may be a determination gene 
for the sympathoadrenal lineage 
The expression of MASH1 in the neural crest-derived 
sympathoadrenal lineage (Patterson 1990)provides the 
one system, so far, in which this gene can be linked to 
the development of a specific neuronal cell type. 
MASHl-positive nuclei are found in the location where 
sympathetic neurons will develop, but 24 hr prior to the 
expression of sympathoadrenal lineage markers. Subse- 
quently, MASH1 expression fades as TH, a marker of 
sympathoadrenal progenitors (Anderson and Axel 1986), 
appears. The reciprocal intensities of MASH1 and TH 






Figure 7. MASH1 expression is positionally restricted in the telencephalon. (A-C) Computer econstruction of serial parasaggital 
sections through one-half of an E 12.5 embryo stained with anti-MASH 1. Blue lines indicate the outlines of individual sections; yellow 
dots indicate individual nuclei• For simplicity, positive nuclei in the spinal cord have been omitted. The image has been rotated to 
present wo different views in A and B. Patches of staining in the hindbrain are more clearly visible in B (arrows). In C, the 
reconstruction is presented without the section outlines; the image has been tilted slightly relative to that in A. (tel) Telencephalon; 
(IV) fourth ventricle; (sc), superior colliculus. Note the domain ofpositive nuclei in the ventral telencephalon (arrows in A and C). The 
arrowhead in A indicates the band of staining in the diencephalon (see also Figs. 5C and 6). (D) Example of one of the parasaggital 
sections used in the serial reconstruction, indicating restricted domain of MASHl-positive nuclei in the ventral region (long arrow). 
Anterior is to the left; posterior is to the right. The crescent-shaped band of MASH1 expression i  the diencephalon is marked by the 
small arrow. The arrowhead indicates the diencephalon. Bar, D 160 ~m. 
expression within individual ganglia at E12.5 strongly 
suggest hat MASH 1-positive cells are developing into 
TH-positive cells. Expression is not detected in other 
locations colonized by neural crest cells, with the excep- 
tion of the gut (see below). The specificity of MASH1 
expression in sympathetic ganglia is consistent with the 
fact that the MASH1 cDNA was initially isolated from 
MAH cells, an immortalized sympathoadrenal progeni- 
tor cell line (Birren and Anderson 1990). In MAH and 
PC12 cells, however, MASH1 is coexpressed with high 
levels of TH (Johnson et al. 1990), a cell state not ob- 
served in vivo. The immortalized nature of these lines 
may induce a partial reversion to an earlier stage of de- 
velopment hat permits MASH1 expression. Whatever 
the case, the expression of MASH1 in PC12 and MAH 
cells clearly does not prevent the expression of later dif- 
ferentiation markers such as TH and SCG10. 
In the PNS, MASH1 is also detected in scattered cells 
within the embryonic gut. One day later in development, 
cells expressing TH can be observed in the gut, as well 
(Baetge and Gershon 1989; Baetge et al. 1990). The ap- 
parent conversion of MASH1- to TH-expressing cells in 
sympathetic ganglia suggests a similar lineal relation- 
ship for such cells in the gut. It is thought that TH- 
expressing cells in the gut are precursors of enteric neu- 
rons (Baetge et al. 1990) and may be similar or identical 
to sympathoadrenal progenitors (J. Carnahan, D. Ander- 
son, and P. Patterson, in prep.). Taken together, these 
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facts that MASH1 is expressed one day earlier than ter- 
minal  differentiation markers and is a transcript ion fac- 
tor (J.E. Johnson, S.J. Birren, T. Saito, and D.J. Anderson, 
unpubl.) raise the possibi l ity that it funct ions in the de- 
terminat ion of this neuronal  sublineage. However, the 
transiently MASHl-posit ive cells of the sympathet ic  
ganglia could potent ial ly give rise to glia as well as to 
neurons (as is the case for achaete-scute-expressing pre- 
cursors in the Drosophila PNS). Because peripheral glia 
develop in other sites of crest migrat ion where MASH1 
is not expressed, the funct ion of MASH1 could, in this 
case, be to generate both glia and neurons in a particular 
place (i.e., the sympathet ic  ganglia) rather than to specify 
cell type per se. Reverse-genetic experiments in the 
mouse should provide a means of resolving this question 
and of determining the extent to which the conservation 
of sequence and lineage specificity between MASH1 and 
the achaete-scute genes reflects a true conservation of 
function. 
Figure 8. MASH1 is expressed in primordial sympathetic gan- 
glia. (A-C) Sections through E l l -E l l .5  embryos stained for 
MASH1 and visualized by immunofluorescence. (A) Arrow- 
heads indicate positive nuclei aggregating adjacent to dorsal 
aorta {ao). Note staining in ventral neural tube (nt). (B) Trans- 
verse but slightly longitudinal section showing positive nuclei 
(arrowheads) that appear to be in the process of migrating to the 
ganglia (arrows.)(C)Longitudinal section showing regularly 
spaced aggregates of MASHl-postive nuclei (arrows) bordering 
the dorsal aorta {ao). The bright white patch to the left of the 
aorta is an artifact. At this stage of development, TH is not yet 
detectable in the sympathetic ganglia (not shown). Bars: (A) 32 
ram; (C)64 txm. 
data suggest that MASH1 expression may identify early 
precursors in the sympathoadrenal /enter ic  lineage. The 
Mater ia ls  and methods  
Recombinant pET-MASH1 production 
A MASH1 cDNA was expressed in bacteria under the control of 
the phage T7 RNA polymerase (Studier et al. 1990). An NcoI site 
was introduced into the first ATG by site-directed mutagenesis 
using the Amersham kit, and a restriction fragment extending 
from this site to a BamHI site 60 bp upstream of the stop codon 
was cloned into the vector pET. Induction of the recombinant 
protein was accomplished by the addition of 0.4 mM IPTG. Re- 
combinant MASH1 was the major polypeptide species observed 
on one-dimensional SDS gels of the inclusion body fraction (not 
shown). The protein was purified further by preparative electro- 
phoresis and was judged to be essentially free of contaminants 
upon re-electrophoresis. 
Immunization procedures 
Mice were immunized with electroeluted, acetone-precipitated 
pET-MASH1 protein emulsified in complete Freund's adjuvant. 
A boost without adjuvant was administered after 2 weeks. Each 
mouse received 75 fag of antigen per injection. Three days after 
the boost, the mouse was sacrificed and its spleen cells fused 
with HL-1 myeloma cells. Cells (2 x 105/well) were plated in 
96-well microtiter dishes containing HL-1 serum-free medium 
with AAT as the selective agent (Kohler and Milstein 1975). 
Antibody screening and immunocytochemical studies 
Initial screening of the hybridoma supernatants was carried out 
by dot blot. One microgram of antigen was spotted on nitrocel- 
lulose paper (BA85, 0.45 ~m; Schleicher & Schuell). The paper 
was then blocked for I hr at room temperature in 3% gelatin, 10 
mg/ml of BSA in Tris-buffered saline (TBS), and incubated with 
hybridoma supernatant overnight at 4°C, followed by horserad- 
ish peroxidase (HRP)-conjugated goat anti-mouse immunoglob- 
ulin (Chemicon) at a 1:200 dilution. Color development was 
performed with 0.5 mg/ml of 4-chloro-l-napthol in 0.01% hy- 
drogen peroxide for 10 rain at room temperature. Positive 
mother clones were then rescreened immediately by immuno- 
histochemistry on paraformaldehyde-fixed PC12 and RAT1 fi- 
broblast cells and on frozen sections of E13.5 neural tubes (a 
stage of development when MASH1 was known to be expressed 
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Figure 9. MASH1 is expressed in the developing gut and precedes but overlaps the initial expression of SCGIO. E11.5 sections were 
double-labeled with anti-MASH1 {A,C) and anti-SCGlO (B,D). Low (A,B) and high (C,D) magnification views of the same field are 
shown. In A, note the MASH 1-positive nuclei (small arrows) migrating into the gut (g). Arrows indicate sympathetic ganglia djacent 
to the dorsal aorta (da); the asterisk (') indicates autofluorescent blood cells. Arrows in B indicate SCG10-positive motor neurons in 
the neural tube. SCG10 immunoreactivity s detectable (D, arrowl in some cells within the same region occupied by MASHl-positive 
nuclei (C, arrow). Sections are from a rostral thoracic region near the bifurcation of the dorsal aorta; in sections from less mature caudal 
regions, SCG10 immunoreactivity s not yet detectable in MASHl-postive sympathetic ganglia. Bars: (A) 64 ~m; (C), 32 Ixm. 
on the basis of earlier Northern blot analysis.) Of 803 wells 
initially screened, 44 positive mother clones were identified by 
the dot blot assay. Four of these clones, in turn, exhibited nu- 
clear staining on PC12 but not RAT1 cells and stained sections 
of E13.5 embryos; the remainder failed to react with the fixed 
MASH1 protein in vivo. 
For immunocytochemistry, rat embryos aged E7.5-E14.5 
(Sprague-Dawley, obtained from Simonsen Breeding Laborato- 
ries; age designated as E0.5 the morning following a midnight 
mating) were fixed by immersion in freshly prepared 4% 
paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) for at least 
1 hr at room temperature, depending on the age of the embryo. 
Fixation carried out at 4°C significantly reduced the sensitivity 
of staining. Staining intensity was also reduced if embryos were 
stored in PBS on ice for significant lengths of time during the 
collection of material, suggesting that the antigen is labile in 
vivo. Following fixation, embryos were equilibrated in 30% su- 
crose in PBS for cryoprotection prior to embedding and cryostat 
sectioning. Immunoperoxidase staining was performed on fro- 
zen sections that were preblocked in 10% horse serum plus 
0.2% Tween 20 in TBS for 30 min at room temperature, fol- 
lowed by incubation with hybridoma supernatant diluted 1 : 1- 
1 : 4 in TBS with 0.1% Tween 20 (TTBS) overnight at 4°C. After 
being washed twice in TTBS for 15 min each, sections were 
developed with an avidin-biotin-HRP system (Vectastain ABC 
kit, Vector Labs, Burlingame, CA) according to the manufactur- 
er's instructions. Endogenous peroxidase activity was elimi- 
nated from the sections by incubating in 0.3% H202 in meth- 
anol for 30 min at room temperature following binding of the 
biotinylated secondary antibody. Color development was per- 
formed by using diaminobenzidine (DAB). Alternatively, sec- 
tions were developed for immunofluorescence following pri- 
mary antibody treatment by incubating with FITC-goat anti- 
mouse IgG (TAGO, Inc.) at 1 : 200. 
Rabbit antibodies to SCG10 were used at 1 : 250 dilution and 
visualized by using rhodamine-goat nti-rabbit (TAGO) anti- 
bodies at 1:200 dilution. Antibody to neurofilament (clone 
BF10, Boehringer Mannheim Biochemicals) was used at a 1 : 40 
dilution and visualized by using biotinylated goat anti-mouse 
IgG and the Vectastain ABC kit. 
Data for serial reconstruction f sections were acquired with 
a motorized microscope stage (Stahl Research) and a digitizer, 
and stored on an IBM PC-XT. The data were transferred to an 
Iris 2400 computer (Silicon Graphics, Mountain View, CA), and 
reconstruction was performed with customized analysis soft- 
ware (J. Knierim and D. Bilitch, unpubl.). 







Figure 10. MASH1 expression in sympathetic ganglia overlaps expression of TH. Double-label immunofluorescence of sections 
through E12.5 sympathetic ganglia stained with anti-MASH1 (A,C) and anti-TH (B,D). (A,B) An individual ganglion is shown at high 
magnification. This ganglion contains a mixture of strongly MASHl-positive (A, long arrow) and weakly positive (A, short arrow) 
nuclei; these are located in TH-negative (B, long arrow) and TH-positive (B, short arrow) regions, respectively. The asterisk ( * ) indicates 
autofluorescent blood cell. (C,D) Semilongitudinal section at lower power, showing three ganglia in a row; caudal is to top; rostral is 
to the bottom. More caudal ganglia have loosely aggregated, strongly MASHl-positive nuclei (C, top arrow) but are only weakly 
TH-positive (D); intermediate ganglia have a mixture of MASHl-positive and -negative cells (C, middle arrow) and contain TH-positive 
cells in the central, MASHl-negative region (D, middle arrow); more rostral ganglia have few MASHl-positive nuclei (C) and many 
bright TH-positive cells (D). The short arrows in C and D indicate autofluorescent blood cells. Bars: (B) 27 ~m; (D) 68 p,m. 
In situ hybridization 
In situ hybridization was performed essentially as described pre- 
viously (Anderson and Axel 1985), The probe used consisted of 
a 175-bp BamHI fragment containing 60 residues of carboxy- 
terminal-coding sequence and 115 residues of 3'-untranslated 
sequence. This probe lies 3' of the bHLH region and does not 
cross-hybridize with MASH2 or any other related sequences. 
Antisense riboprobes for in situ hybridization were generated by 
transcription of BamHI-linearized templates with T7 RNA 
polymerase. 
In vitro transcription a d translation 
In vitro transcription and translation of cDNA clones were per- 
formed as described (Davis et al. 1990) with a rabbit reticulocyte 
lysate kit and other reagents from Promega. The MASH1 and 
MASH2 cDNAs containing the complete coding regions were 
described previously (Johnson et al. 1990). The rat El2 cDNA 
clone was isolated from a MAH cell cDNA library (S. Birren, 
unpubl.) and will be described separately (J.E. Johnson, S.J. Bir- 
ren, T. Saito, and D.J. Anderson, in prep.). 
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